
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, we will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **IGKC, IGHG1, IGHG3, IGHG4, IGHGP, IGHA1, IGHM**: These are immunoglobulin genes, indicating antibody production, a hallmark of B cells and plasma cells.<br>- **MZB1**: Known to be involved in the unfolded protein response and is highly expressed in plasma cells.<br>- **TNFRSF17 (BCMA)**: A receptor involved in B cell maturation and survival, often expressed in plasma cells.<br>- **JCHAIN**: Encodes the joining chain of multimeric IgA and IgM, typically found in plasma cells.<br>- **FCRL5**: A receptor expressed on B cells, particularly memory B cells and plasma cells.<br>- **CD38**: A multifunctional enzyme and receptor, highly expressed on plasma cells.<br>- **SLAMF7**: A surface protein expressed on plasma cells and some subsets of B cells.<br>- **PRDM1 (Blimp-1)**: A transcription factor critical for plasma cell differentiation.<br>- **CD27**: A member of the TNF-receptor superfamily, expressed on memory B cells and plasma cells.<br><br>### Step 2: List the Key Cell Type Markers<br>- **CD79A, CD79B**: Components of the B cell receptor complex, indicating B cell lineage.<br>- **POU2AF1 (BOB.1/OBF.1)**: A transcriptional coactivator involved in B cell development.<br>- **CD38, SLAMF7, PRDM1, TNFRSF17**: As mentioned, these are markers indicative of plasma cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Cell Atlas, PanglaoDB, and literature on scRNA-seq of immune cells, the markers listed are predominantly associated with B cells, particularly plasma cells. The presence of immunoglobulin genes, CD38, SLAMF7, and PRDM1 strongly suggests a plasma cell identity.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of these markers, the most likely general cell type is **Plasma Cells**. This is supported by the high expression of immunoglobulin genes, CD38, PRDM1, and other plasma cell-specific markers.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Mature Plasma Cells**: Given the high expression of immunoglobulin genes, CD38, and PRDM1, mature plasma cells are the most likely subtype.<br>2. **Memory B Cells transitioning to Plasma Cells**: The presence of CD27 and FCRL5 suggests a possible transition state.<br>3. **Plasmablasts**: These are precursors to plasma cells and may express some of the markers listed, though typically with lower immunoglobulin expression.<br><br>The most likely subtype based on the markers is **Mature Plasma Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset indicates that the cell cluster is most likely composed of plasma cells. The high expression of immunoglobulin genes, along with markers such as CD38, PRDM1, and TNFRSF17, strongly supports this annotation. Among the subtypes, mature plasma cells are the most probable, given the expression profile.<br><br>FINAL ANNOTATION COMPLETED
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. The markers listed, such as IGKC, IGHG1, IGHG3, MZB1, TNFRSF17, JCHAIN, FCRL5, CD38, SLAMF7, PRDM1, and CD27, are all present in the provided marker list and are well-known markers for plasma cells and B cells. The analysis correctly identifies the cell type as plasma cells, with a strong emphasis on mature plasma cells, which is supported by the high expression of immunoglobulin genes and other plasma cell-specific markers.<br><br>The consideration of potential subtypes, such as memory B cells transitioning to plasma cells and plasmablasts, is appropriate given the presence of markers like CD27 and FCRL5. However, the primary annotation of mature plasma cells is well-supported by the data.<br><br>No evidence of mixed cell types is strongly indicated by the marker list, so no further investigation is necessary at this time. The annotation is thorough and aligns with known databases and literature on plasma cell markers.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Plasma Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Mature Plasma Cells</li><li>Memory B Cells transitioning to Plasma Cells</li><li>Plasmablasts</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results provided are scientifically accurate and well-reasoned. The analysis correctly identifies the main cell type as plasma cells, which is supported by the presence of key markers such as IGKC, IGHG1, IGHG3, MZB1, TNFRSF17, JCHAIN, FCRL5, CD38, SLAMF7, PRDM1, and CD27. These markers are well-known indicators of plasma cells and B cells, and their presence in the marker list justifies the annotation.<br><br>The annotation process demonstrates a balanced consideration of multiple markers, rather than over-focusing on a specific one. The analysis takes into account both functional markers and cell type-specific markers, which provides a comprehensive view of the cell populations present. The identification of subtypes, such as mature plasma cells, memory B cells transitioning to plasma cells, and plasmablasts, is appropriate and reflects a nuanced understanding of the data.<br><br>The annotation also considers the rank of the markers, with immunoglobulin genes appearing prominently, which aligns with their importance in identifying plasma cells. The analysis does not show any obvious misclassifications or oversights, and it aligns well with known databases and literature on plasma cell markers.<br><br>Overall, the annotation captures the general picture of the cell populations effectively, providing a thorough and accurate representation of the data. The consideration of potential subtypes and the validation of the results further strengthen the analysis.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    